Premium
Revisiting the immunocytochemical detection of Neurogenin 3 expression in mouse and man
Author(s) -
Honoré C.,
Rescan C.,
Hald J.,
McGrath P. S.,
Petersen M. B. K.,
Hansson M.,
Klein T.,
Østergaard S.,
Wells J. M.,
Madsen O. D.
Publication year - 2016
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1111/dom.12718
Subject(s) - enteroendocrine cell , biology , embryonic stem cell , monoclonal antibody , pancreas , progenitor cell , reprogramming , epitope , antibody , microbiology and biotechnology , computational biology , endocrine system , immunology , stem cell , cell , genetics , endocrinology , gene , hormone
During embryonic development, endocrine cells of the pancreas are specified from multipotent progenitors. The transcription factor Neurogenin 3 ( NEUROG3 ) is critical for this development and it has been shown that all endocrine cells of the pancreas arise from endocrine progenitors expressing NEUROG3 . A thorough understanding of the role of NEUROG3 during development, directed differentiation of pluripotent stem cells and in models of cellular reprogramming, will guide future efforts directed at finding novel sources of β‐cells for cell replacement therapies. In this article, we review the expression and function of NEUROG3 in both mouse and human and present the further characterization of a monoclonal antibody directed against NEUROG3 . This antibody has been previously been used for detection of both mouse and human NEUROG3 . However, our results suggest that the epitope recognized by this antibody is specific to mouse NEUROG3 . Thus, we have also generated a monoclonal antibody specifically recognizing human NEUROG3 and present the characterization of this antibody here. Together, these antibodies will provide useful tools for future studies of NEUROG3 expression, and the data presented in this article suggest that recently described expression patterns of NEUROG3 in human foetal and adult pancreas should be re‐examined.